SPOT NEWS of Singapore
SPOT NEWS of Singapore
According to comprehensive industry analysis, the market is projected to grow from USD 920.50 million in 2025 to USD 4,361.38 million by 2032, exhibiting an exceptional CAGR of 22.50% during the forecast period.
According to comprehensive industry analysis, the market is projected to grow from USD 1.78 billion in 2025 to USD 3.42 billion by 2032, exhibiting a strong CAGR of 8.5% during the forecast period.
Contrast medium market was valued at USD 5,811 million in 2024 and is expected to reach USD 7,987 million by 2031, exhibiting a CAGR of 4.8% during the forecast period.
Intracranial stents market was valued at USD 222 million in 2024 and is projected to grow from USD 228.6 million in 2025 to USD 284 million by 2031, registering a CAGR of 3.7% during the forecast period.
According to comprehensive industry analysis, the market is projected to reach USD 97.28 million by 2032, exhibiting a CAGR of 3.40% during the forecast period.
Portable Oxygen Concentrators (POC) market was valued at USD 1.154 billion in 2024 and is forecasted to reach USD 2.896 billion by 2031, registering a robust CAGR of 14.4% during…
market is anticipated to experience strong growth, expanding from USD 1.19 billion in 2025 to USD 1.95 billion by 2031, representing a CAGR of 8.8% during the forecast period.
Diagnostic Ultrasound Devices market is set for robust growth, expanding from USD 12.15 billion in 2025 to USD 18.83 billion by 2031, representing a CAGR of 7.8% over the forecast period.
According to comprehensive industry analysis, the market is projected to reach USD 542.1 million by 2032, exhibiting a CAGR of 4.95% during the forecast period.
Precision medicine market was valued at USD 130,400 million in 2024 and is projected to grow to USD 256,430 million by 2031, reflecting a CAGR of 10.4% during the forecast period.
According to comprehensive industry analysis, the market is projected to grow from USD 1.45 billion in 2025 to USD 2.15 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period.
Global Chancroid Testing market was valued at USD 78.5 million in 2024 and is projected to reach USD 112.3 million by 2032, registering a compound annual growth rate (CAGR) of 4.6% during the forecast period.